Nanomedicines Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicines Market Size Growth Rate by Type: 2017 VS 2022 VS 2030
1.2.2 Nanoparticles
1.2.3 Nanoshells
1.2.4 Nanotubes
1.2.5 Nanodevices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nanomedicines Market Share by Application: 2017 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicines Market Perspective (2017-2030)
2.2 Nanomedicines Growth Trends by Region
2.2.1 Nanomedicines Market Size by Region: 2017 VS 2022 VS 2030
2.2.2 Nanomedicines Historic Market Size by Region (2017-2023)
2.2.3 Nanomedicines Forecasted Market Size by Region (2023-2030)
2.3 Nanomedicines Market Dynamics
2.3.1 Nanomedicines Industry Trends
2.3.2 Nanomedicines Market Drivers
2.3.3 Nanomedicines Market Challenges
2.3.4 Nanomedicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicines Players by Revenue
3.1.1 Global Top Nanomedicines Players by Revenue (2017-2023)
3.1.2 Global Nanomedicines Revenue Market Share by Players (2017-2023)
3.2 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nanomedicines Revenue
3.4 Global Nanomedicines Market Concentration Ratio
3.4.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2022
3.5 Nanomedicines Key Players Head office and Area Served
3.6 Key Players Nanomedicines Product Solution and Service
3.7 Date of Enter into Nanomedicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicines Breakdown Data by Type
4.1 Global Nanomedicines Historic Market Size by Type (2017-2023)
4.2 Global Nanomedicines Forecasted Market Size by Type (2023-2030)
5 Nanomedicines Breakdown Data by Application
5.1 Global Nanomedicines Historic Market Size by Application (2017-2023)
5.2 Global Nanomedicines Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Nanomedicines Market Size (2017-2030)
6.2 North America Nanomedicines Market Size by Country (2017-2023)
6.3 North America Nanomedicines Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Nanomedicines Market Size (2017-2030)
7.2 Europe Nanomedicines Market Size by Country (2017-2023)
7.3 Europe Nanomedicines Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicines Market Size (2017-2030)
8.2 Asia-Pacific Nanomedicines Market Size by Country (2017-2023)
8.3 Asia-Pacific Nanomedicines Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Nanomedicines Market Size (2017-2030)
9.2 Latin America Nanomedicines Market Size by Country (2017-2023)
9.3 Latin America Nanomedicines Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicines Market Size (2017-2030)
10.2 Middle East & Africa Nanomedicines Market Size by Country (2017-2023)
10.3 Middle East & Africa Nanomedicines Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Nanomedicines Introduction
11.1.4 Abbott Revenue in Nanomedicines Business (2017-2023)
11.1.5 Abbott Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nanomedicines Introduction
11.2.4 GE Healthcare Revenue in Nanomedicines Business (2017-2023)
11.2.5 GE Healthcare Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Nanomedicines Introduction
11.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2017-2023)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Nanomedicines Introduction
11.4.4 Merck Revenue in Nanomedicines Business (2017-2023)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Nanomedicines Introduction
11.5.4 Pfizer Revenue in Nanomedicines Business (2017-2023)
11.5.5 Pfizer Recent Development
11.6 CombiMatrix
11.6.1 CombiMatrix Company Detail
11.6.2 CombiMatrix Business Overview
11.6.3 CombiMatrix Nanomedicines Introduction
11.6.4 CombiMatrix Revenue in Nanomedicines Business (2017-2023)
11.6.5 CombiMatrix Recent Development
11.7 Celgene
11.7.1 Celgene Company Detail
11.7.2 Celgene Business Overview
11.7.3 Celgene Nanomedicines Introduction
11.7.4 Celgene Revenue in Nanomedicines Business (2017-2023)
11.7.5 Celgene Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Detail
11.8.2 Mallinckrodt Business Overview
11.8.3 Mallinckrodt Nanomedicines Introduction
11.8.4 Mallinckrodt Revenue in Nanomedicines Business (2017-2023)
11.8.5 Mallinckrodt Recent Development
11.9 Sigma-Tau Pharmaceuticals
11.9.1 Sigma-Tau Pharmaceuticals Company Detail
11.9.2 Sigma-Tau Pharmaceuticals Business Overview
11.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2023)
11.9.5 Sigma-Tau Pharmaceuticals Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Detail
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Nanomedicines Introduction
11.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2023)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Nanomedicines Introduction
11.11.4 Nanosphere Revenue in Nanomedicines Business (2017-2023)
11.11.5 Nanosphere Recent Development
11.12 UCB SA
11.12.1 UCB SA Company Detail
11.12.2 UCB SA Business Overview
11.12.3 UCB SA Nanomedicines Introduction
11.12.4 UCB SA Revenue in Nanomedicines Business (2017-2023)
11.12.5 UCB SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Nanomedicines Market Size Growth Rate by Type (US$ Million): 2017 VS 2022 VS 2030
Table 2. Key Players of Nanoparticles
Table 3. Key Players of Nanoshells
Table 4. Key Players of Nanotubes
Table 5. Key Players of Nanodevices
Table 6. Key Players of Others
Table 7. Global Nanomedicines Market Size Growth by Application (US$ Million): 2017 VS 2022 VS 2030
Table 8. Global Nanomedicines Market Size by Region (US$ Million): 2017 VS 2022 VS 2030
Table 9. Global Nanomedicines Market Size by Region (2017-2023) & (US$ Million)
Table 10. Global Nanomedicines Market Share by Region (2017-2023)
Table 11. Global Nanomedicines Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 12. Global Nanomedicines Market Share by Region (2023-2030)
Table 13. Nanomedicines Market Trends
Table 14. Nanomedicines Market Drivers
Table 15. Nanomedicines Market Challenges
Table 16. Nanomedicines Market Restraints
Table 17. Global Nanomedicines Revenue by Players (2017-2023) & (US$ Million)
Table 18. Global Nanomedicines Market Share by Players (2017-2023)
Table 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2022)
Table 20. Ranking of Global Top Nanomedicines Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Nanomedicines Revenue (CR5 and HHI) & (2017-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicines Product Solution and Service
Table 24. Date of Enter into Nanomedicines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicines Market Size by Type (2017-2023) & (US$ Million)
Table 27. Global Nanomedicines Revenue Market Share by Type (2017-2023)
Table 28. Global Nanomedicines Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 29. Global Nanomedicines Revenue Market Share by Type (2023-2030)
Table 30. Global Nanomedicines Market Size by Application (2017-2023) & (US$ Million)
Table 31. Global Nanomedicines Revenue Market Share by Application (2017-2023)
Table 32. Global Nanomedicines Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 33. Global Nanomedicines Revenue Market Share by Application (2023-2030)
Table 34. North America Nanomedicines Market Size by Country (2017-2023) & (US$ Million)
Table 35. North America Nanomedicines Market Size by Country (2023-2030) & (US$ Million)
Table 36. Europe Nanomedicines Market Size by Country (2017-2023) & (US$ Million)
Table 37. Europe Nanomedicines Market Size by Country (2023-2030) & (US$ Million)
Table 38. Asia-Pacific Nanomedicines Market Size by Region (2017-2023) & (US$ Million)
Table 39. Asia-Pacific Nanomedicines Market Size by Region (2023-2030) & (US$ Million)
Table 40. Latin America Nanomedicines Market Size by Country (2017-2023) & (US$ Million)
Table 41. Latin America Nanomedicines Market Size by Country (2023-2030) & (US$ Million)
Table 42. Middle East & Africa Nanomedicines Market Size by Country (2017-2023) & (US$ Million)
Table 43. Middle East & Africa Nanomedicines Market Size by Country (2023-2030) & (US$ Million)
Table 44. Abbott Company Detail
Table 45. Abbott Business Overview
Table 46. Abbott Nanomedicines Product
Table 47. Abbott Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 48. Abbott Recent Development
Table 49. GE Healthcare Company Detail
Table 50. GE Healthcare Business Overview
Table 51. GE Healthcare Nanomedicines Product
Table 52. GE Healthcare Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 53. GE Healthcare Recent Development
Table 54. Johnson & Johnson Company Detail
Table 55. Johnson & Johnson Business Overview
Table 56. Johnson & Johnson Nanomedicines Product
Table 57. Johnson & Johnson Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 58. Johnson & Johnson Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Nanomedicines Product
Table 62. Merck Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Nanomedicines Product
Table 67. Pfizer Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. CombiMatrix Company Detail
Table 70. CombiMatrix Business Overview
Table 71. CombiMatrix Nanomedicines Product
Table 72. CombiMatrix Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 73. CombiMatrix Recent Development
Table 74. Celgene Company Detail
Table 75. Celgene Business Overview
Table 76. Celgene Nanomedicines Product
Table 77. Celgene Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 78. Celgene Recent Development
Table 79. Mallinckrodt Company Detail
Table 80. Mallinckrodt Business Overview
Table 81. Mallinckrodt Nanomedicines Product
Table 82. Mallinckrodt Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 83. Mallinckrodt Recent Development
Table 84. Sigma-Tau Pharmaceuticals Company Detail
Table 85. Sigma-Tau Pharmaceuticals Business Overview
Table 86. Sigma-Tau Pharmaceuticals Nanomedicines Product
Table 87. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 88. Sigma-Tau Pharmaceuticals Recent Development
Table 89. Teva Pharmaceutical Company Detail
Table 90. Teva Pharmaceutical Business Overview
Table 91. Teva Pharmaceutical Nanomedicines Product
Table 92. Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 93. Teva Pharmaceutical Recent Development
Table 94. Nanosphere Company Detail
Table 95. Nanosphere Business Overview
Table 96. Nanosphere NanomedicinesProduct
Table 97. Nanosphere Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 98. Nanosphere Recent Development
Table 99. UCB SA Company Detail
Table 100. UCB SA Business Overview
Table 101. UCB SA NanomedicinesProduct
Table 102. UCB SA Revenue in Nanomedicines Business (2017-2023) & (US$ Million)
Table 103. UCB SA Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicines Market Share by Type: 2022 VS 2030
Figure 2. Nanoparticles Features
Figure 3. Nanoshells Features
Figure 4. Nanotubes Features
Figure 5. Nanodevices Features
Figure 6. Others Features
Figure 7. Global Nanomedicines Market Share by Application in 2022 & 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Nanomedicines Report Years Considered
Figure 12. Global Nanomedicines Market Size (US$ Million), Year-over-Year: 2017-2030
Figure 13. Global Nanomedicines Market Size, (US$ Million), 2017 VS 2022 VS 2030
Figure 14. Global Nanomedicines Market Share by Region: 2022 VS 2030
Figure 15. Global Nanomedicines Market Share by Players in 2022
Figure 16. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2022
Figure 18. North America Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 19. North America Nanomedicines Market Share by Country (2017-2030)
Figure 20. United States Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 21. Canada Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 22. Europe Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 23. Europe Nanomedicines Market Share by Country (2017-2030)
Figure 24. Germany Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 25. France Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 26. U.K. Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 27. Italy Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 28. Russia Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 29. Nordic Countries Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 30. Asia-Pacific Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 31. Asia-Pacific Nanomedicines Market Share by Region (2017-2030)
Figure 32. China Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 33. Japan Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 34. South Korea Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 35. Southeast Asia Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 36. India Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 37. Australia Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 38. Latin America Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 39. Latin America Nanomedicines Market Share by Country (2017-2030)
Figure 40. Mexico Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 41. Brazil Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 42. Middle East & Africa Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 43. Middle East & Africa Nanomedicines Market Share by Country (2017-2030)
Figure 44. Turkey Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 45. Saudi Arabia Nanomedicines Market Size YoY Growth (2017-2030) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 47. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 49. Merck Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 50. Pfizer Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 51. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 52. Celgene Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 53. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 54. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 56. Nanosphere Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 57. UCB SA Revenue Growth Rate in Nanomedicines Business (2017-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Industry Market Size
